Literature DB >> 30071520

Prodigiosin Inhibits Proliferation, Migration, and Invasion of Nasopharyngeal Cancer Cells.

Yongze Liu1,2, Han Zhou1,2, Xiaofeng Ma1,2, Chuanyao Lin1,2, Ling Lu1,2, Dingding Liu1,2, Dengbin Ma1,2, Xia Gao1,2, Xiao Yun Qian1,2.   

Abstract

BACKGROUND/AIMS: Nasopharyngeal carcinoma remains a devastating and difficult disease to treat. This study explores the antineoplastic effect of prodigiosin on nasopharyngeal cancer cells.
METHODS: Human nasopharyngeal carcinoma CNE2 cells and human normal nasopharyngeal epithelial NP69 cells were obtained and treated with prodigiosin or fluorouracil (5-FU). Colony formation assay was performed to screen for the optimal experimental concentrations of prodigiosin and 5-FU, and MTT assay was used to examine cell proliferative ability. Flow cytometry was used to examine cell cycle distribution, the scratch test was employed to examine cell migration, and Transwell migration assay (Boyden chamber) was used to study cell invasion.
RESULTS: The optimal concentrations of prodigiosin and 5-FU for treatment were 4 mg/L and 0.35 mg/L, respectively. Both prodigiosin and 5-FU inhibited tumor cell proliferation. The percentage of cells in G0/G1 phase was higher and the percentage of cells in S phase was lower in the prodigiosin and 5-FU groups than in the untreated groups. Both prodigiosin and 5-FU inhibited tumor cell migration and tumor cell invasion.
CONCLUSIONS: Our results suggest that prodigiosin can inhibit proliferation, migration, and invasion of nasopharyngeal carcinoma cells.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cell Cycle; Invasion; Migration; Nasopharyngeal Cancer; Prodigiosin; Proliferation

Mesh:

Substances:

Year:  2018        PMID: 30071520     DOI: 10.1159/000492278

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

1.  The effectiveness of antimicrobial photodynamic therapy with prodigiosin against reference strains of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

Authors:  Amin Derakhshanfar; Banafsheh Rastegari; Hossein Sharifi; Hossein Khajeh-Zadeh; Javad Moayedi
Journal:  Lasers Med Sci       Date:  2022-09-26       Impact factor: 2.555

2.  Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117.

Authors:  Jelena Lazic; Sanja Skaro Bogojevic; Sandra Vojnovic; Ivana Aleksic; Dusan Milivojevic; Martin Kretzschmar; Tanja Gulder; Milos Petkovic; Jasmina Nikodinovic-Runic
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Selective Cytotoxic Activity of Prodigiosin@halloysite Nanoformulation.

Authors:  Ivan Guryanov; Ekaterina Naumenko; Farida Akhatova; Giuseppe Lazzara; Giuseppe Cavallaro; Läysän Nigamatzyanova; Rawil Fakhrullin
Journal:  Front Bioeng Biotechnol       Date:  2020-05-26

Review 4.  The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression.

Authors:  Anna Walczak; Kinga Gradzik; Jacek Kabzinski; Karolina Przybylowska-Sygut; Ireneusz Majsterek
Journal:  Oxid Med Cell Longev       Date:  2019-02-03       Impact factor: 6.543

5.  Structural and functional characterization of β2 -glycoprotein I domain 1 in anti-melanoma cell migration.

Authors:  Shr-Jeng Jim Leu; Tzong-Yi Lee; Shu-Wei Cheng; Meng-Ying Tsai; Yu-Shan Lin; Tzeon-Jye Chiou; Kai-Yao Huang; An-Na Chiang
Journal:  Cancer Sci       Date:  2019-05-15       Impact factor: 6.716

6.  Amikacin Suppresses Human Breast Cancer Cell MDA-MB-231 Migration and Invasion.

Authors:  Yun-Hsin Wang; Yau-Hung Chen; Wen-Hao Shen
Journal:  Toxics       Date:  2020-11-20

Review 7.  Recent Advances in Prodigiosin as a Bioactive Compound in Nanocomposite Applications.

Authors:  Rafael G Araújo; Natalia Rodríguez Zavala; Carlos Castillo-Zacarías; Mario E Barocio; Enrique Hidalgo-Vázquez; Lizeth Parra-Arroyo; Jesús Alfredo Rodríguez-Hernández; María Adriana Martínez-Prado; Juan Eduardo Sosa-Hernández; Manuel Martínez-Ruiz; Wei Ning Chen; Damià Barceló; Hafiz M N Iqbal; Roberto Parra-Saldívar
Journal:  Molecules       Date:  2022-08-05       Impact factor: 4.927

8.  Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy.

Authors:  Zahra Arshadi; Sayedeh Azimeh Hosseini; Daryoush Fatehi; Seyed Abbas Mirzaei; Fatemeh Elahian
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.